Crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments
The invention relates to a crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, to a method for the preparation thereof, as well as to the use thereof for preparing medicaments.
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Kraemer, Gerd Martin, Hans-Juergen Adelgoss, Gebhard Dugi, Klaus Duran, Adil Eickelmann, Peter Maier, Steffen Pinnetti, Sabine Ritter, Regine Schilcher, Gebhard Streicher, Ruediger Thomas, Leo |
| description | The invention relates to a crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, to a method for the preparation thereof, as well as to the use thereof for preparing medicaments. |
| format | Patent |
| fullrecord | <record><control><sourceid>uspatents_EFH</sourceid><recordid>TN_cdi_uspatents_grants_07524822</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>07524822</sourcerecordid><originalsourceid>FETCH-uspatents_grants_075248223</originalsourceid><addsrcrecordid>eNqNjk1uwjAQhbPpoqK9wyxBYiQSgmAPVOzYdFdV1YhMEkuOx7IdqemqZ-IgcIeepHbSA3QzT_PeNz-P2X3vBh9Ia2UYanEdSA35z_cV5zl2HNpBj2WBZTLf5gXWuhcnWI6xfA62ZROBCX7HTeKmBvMT2sHRl2hcJ_uMtysesNH9RVJgxKuKl0Aw7qrSB6CCB-vYkqOgxACZCkLL0HtO6jh-mLiJUaaJw5W6UMcm-KfsoSbt-flPZxm8HF_3J-y9pZCIjybejbLabopyVxTrfyC_RUdqCw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments</title><source>USPTO Issued Patents</source><creator>Kraemer, Gerd ; Martin, Hans-Juergen ; Adelgoss, Gebhard ; Dugi, Klaus ; Duran, Adil ; Eickelmann, Peter ; Maier, Steffen ; Pinnetti, Sabine ; Ritter, Regine ; Schilcher, Gebhard ; Streicher, Ruediger ; Thomas, Leo</creator><creatorcontrib>Kraemer, Gerd ; Martin, Hans-Juergen ; Adelgoss, Gebhard ; Dugi, Klaus ; Duran, Adil ; Eickelmann, Peter ; Maier, Steffen ; Pinnetti, Sabine ; Ritter, Regine ; Schilcher, Gebhard ; Streicher, Ruediger ; Thomas, Leo ; Ajinomoto Co., Inc ; Boehringer Ingelheim International GmbH</creatorcontrib><description>The invention relates to a crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, to a method for the preparation thereof, as well as to the use thereof for preparing medicaments.</description><language>eng</language><creationdate>2009</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7524822$$EPDF$$P50$$Guspatents$$Hfree_for_read</linktopdf><link.rule.ids>230,308,776,798,881,64015</link.rule.ids><linktorsrc>$$Uhttps://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7524822$$EView_record_in_USPTO$$FView_record_in_$$GUSPTO$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Kraemer, Gerd</creatorcontrib><creatorcontrib>Martin, Hans-Juergen</creatorcontrib><creatorcontrib>Adelgoss, Gebhard</creatorcontrib><creatorcontrib>Dugi, Klaus</creatorcontrib><creatorcontrib>Duran, Adil</creatorcontrib><creatorcontrib>Eickelmann, Peter</creatorcontrib><creatorcontrib>Maier, Steffen</creatorcontrib><creatorcontrib>Pinnetti, Sabine</creatorcontrib><creatorcontrib>Ritter, Regine</creatorcontrib><creatorcontrib>Schilcher, Gebhard</creatorcontrib><creatorcontrib>Streicher, Ruediger</creatorcontrib><creatorcontrib>Thomas, Leo</creatorcontrib><creatorcontrib>Ajinomoto Co., Inc</creatorcontrib><creatorcontrib>Boehringer Ingelheim International GmbH</creatorcontrib><title>Crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments</title><description>The invention relates to a crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, to a method for the preparation thereof, as well as to the use thereof for preparing medicaments.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2009</creationdate><recordtype>patent</recordtype><sourceid>EFH</sourceid><recordid>eNqNjk1uwjAQhbPpoqK9wyxBYiQSgmAPVOzYdFdV1YhMEkuOx7IdqemqZ-IgcIeepHbSA3QzT_PeNz-P2X3vBh9Ia2UYanEdSA35z_cV5zl2HNpBj2WBZTLf5gXWuhcnWI6xfA62ZROBCX7HTeKmBvMT2sHRl2hcJ_uMtysesNH9RVJgxKuKl0Aw7qrSB6CCB-vYkqOgxACZCkLL0HtO6jh-mLiJUaaJw5W6UMcm-KfsoSbt-flPZxm8HF_3J-y9pZCIjybejbLabopyVxTrfyC_RUdqCw</recordid><startdate>20090428</startdate><enddate>20090428</enddate><creator>Kraemer, Gerd</creator><creator>Martin, Hans-Juergen</creator><creator>Adelgoss, Gebhard</creator><creator>Dugi, Klaus</creator><creator>Duran, Adil</creator><creator>Eickelmann, Peter</creator><creator>Maier, Steffen</creator><creator>Pinnetti, Sabine</creator><creator>Ritter, Regine</creator><creator>Schilcher, Gebhard</creator><creator>Streicher, Ruediger</creator><creator>Thomas, Leo</creator><scope>EFH</scope></search><sort><creationdate>20090428</creationdate><title>Crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments</title><author>Kraemer, Gerd ; Martin, Hans-Juergen ; Adelgoss, Gebhard ; Dugi, Klaus ; Duran, Adil ; Eickelmann, Peter ; Maier, Steffen ; Pinnetti, Sabine ; Ritter, Regine ; Schilcher, Gebhard ; Streicher, Ruediger ; Thomas, Leo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-uspatents_grants_075248223</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2009</creationdate><toplevel>online_resources</toplevel><creatorcontrib>Kraemer, Gerd</creatorcontrib><creatorcontrib>Martin, Hans-Juergen</creatorcontrib><creatorcontrib>Adelgoss, Gebhard</creatorcontrib><creatorcontrib>Dugi, Klaus</creatorcontrib><creatorcontrib>Duran, Adil</creatorcontrib><creatorcontrib>Eickelmann, Peter</creatorcontrib><creatorcontrib>Maier, Steffen</creatorcontrib><creatorcontrib>Pinnetti, Sabine</creatorcontrib><creatorcontrib>Ritter, Regine</creatorcontrib><creatorcontrib>Schilcher, Gebhard</creatorcontrib><creatorcontrib>Streicher, Ruediger</creatorcontrib><creatorcontrib>Thomas, Leo</creatorcontrib><creatorcontrib>Ajinomoto Co., Inc</creatorcontrib><creatorcontrib>Boehringer Ingelheim International GmbH</creatorcontrib><collection>USPTO Issued Patents</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Kraemer, Gerd</au><au>Martin, Hans-Juergen</au><au>Adelgoss, Gebhard</au><au>Dugi, Klaus</au><au>Duran, Adil</au><au>Eickelmann, Peter</au><au>Maier, Steffen</au><au>Pinnetti, Sabine</au><au>Ritter, Regine</au><au>Schilcher, Gebhard</au><au>Streicher, Ruediger</au><au>Thomas, Leo</au><aucorp>Ajinomoto Co., Inc</aucorp><aucorp>Boehringer Ingelheim International GmbH</aucorp><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments</title><date>2009-04-28</date><risdate>2009</risdate><abstract>The invention relates to a crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, to a method for the preparation thereof, as well as to the use thereof for preparing medicaments.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_uspatents_grants_07524822 |
| source | USPTO Issued Patents |
| title | Crystalline form of 1′-(1-methylethyl)-4′-[(2-fluoro-4-methoxyphenyl)methyl]-5′-methyl-1H-pyrazol-3′-O-β-D-glucopyranoside, a method for its preparation and the use thereof for preparing medicaments |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T23%3A35%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-uspatents_EFH&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Kraemer,%20Gerd&rft.aucorp=Ajinomoto%20Co.,%20Inc&rft.date=2009-04-28&rft_id=info:doi/&rft_dat=%3Cuspatents_EFH%3E07524822%3C/uspatents_EFH%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |